Device-Aided Therapies in Parkinson's disease
Device-Aided Therapies in Parkinson's disease
Falup-Pecurariu, Cristian; Odin, Per; Chaudhuri, Ray
Elsevier Science Publishing Co Inc
10/2024
254
Dura
9780443314681
15 a 20 dias
Descrição não disponível.
1. The concept of continuous dopaminergic stimulation
Peter Jenner and Wolfgang H. Jost
2. Apomorphine Infusion
Teus van Laar
3. LCIG
Per Odin Sr.
4. LECIG
Dag Nyholm
5. Foslevodopa/Foscarbidopa
K Ray Chaudhuri and Karolina Poplawska-Domaszewicz
6. ND0612
Fabrizio Stocchi
7. STN-DBS
Elena Moro
8. Pallidal DBS
Keyoumars Ashkan
9. MRgFUS
Guenther Deuschl
10. Vestibular Neurostimulation
Aleksandra M. Podlewska
11. Patient selection and choice of therapy
Cristian Falup-Pecurariu
12. The future: Stem cells? Gene therapy?
Gesine Paul-Visse
13. The future: Trophic factors
Jeffrey H. Kordower
14. Devices and the dashboard for PD
K Ray Chaudhuri and Karolina Poplawska-Domaszewicz
Peter Jenner and Wolfgang H. Jost
2. Apomorphine Infusion
Teus van Laar
3. LCIG
Per Odin Sr.
4. LECIG
Dag Nyholm
5. Foslevodopa/Foscarbidopa
K Ray Chaudhuri and Karolina Poplawska-Domaszewicz
6. ND0612
Fabrizio Stocchi
7. STN-DBS
Elena Moro
8. Pallidal DBS
Keyoumars Ashkan
9. MRgFUS
Guenther Deuschl
10. Vestibular Neurostimulation
Aleksandra M. Podlewska
11. Patient selection and choice of therapy
Cristian Falup-Pecurariu
12. The future: Stem cells? Gene therapy?
Gesine Paul-Visse
13. The future: Trophic factors
Jeffrey H. Kordower
14. Devices and the dashboard for PD
K Ray Chaudhuri and Karolina Poplawska-Domaszewicz
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Advanced Parkinson's disease; Akinesia; Apomorphine; Cell therapy; Cell therapy clinical trial; Clinical trials; Continuous dopaminergic stimulation; Continuous drug delivery; Continuous subcutaneous apomorphine infusion; DBS; DBS outcomes; Deep brain stimulation; Device aided therapies; Device-aided therapies; Dopaminergic neurons; Early morning off; Essential tremor; Focused ultrasound; Foslevodopa; Foslevodopa/foscarbidopa; Future treatment; Globus pallidus internus; Human embryonic stem cells; Induced pluripotent stem cells; Infusion; Intestinal gel; KeywordNeurotrophins; Levodopa; Levodopa-carbidopa intestinal gel; Levodopa-entacapone-carbidopa; Levodopa-entacapone-carbidopa intestinal gel; Motor fluctuations; Movement disorders; Neuromodulation; Parkinsonian tremor; Parkinson's disease; Pharmacokinetics; Pump; Response fluctuations; STN-DBS; Subcutaneous; Subcutaneous infusion; Subthalamic nucleus; Technical principles; Transplantation; Treatment of tremor
1. The concept of continuous dopaminergic stimulation
Peter Jenner and Wolfgang H. Jost
2. Apomorphine Infusion
Teus van Laar
3. LCIG
Per Odin Sr.
4. LECIG
Dag Nyholm
5. Foslevodopa/Foscarbidopa
K Ray Chaudhuri and Karolina Poplawska-Domaszewicz
6. ND0612
Fabrizio Stocchi
7. STN-DBS
Elena Moro
8. Pallidal DBS
Keyoumars Ashkan
9. MRgFUS
Guenther Deuschl
10. Vestibular Neurostimulation
Aleksandra M. Podlewska
11. Patient selection and choice of therapy
Cristian Falup-Pecurariu
12. The future: Stem cells? Gene therapy?
Gesine Paul-Visse
13. The future: Trophic factors
Jeffrey H. Kordower
14. Devices and the dashboard for PD
K Ray Chaudhuri and Karolina Poplawska-Domaszewicz
Peter Jenner and Wolfgang H. Jost
2. Apomorphine Infusion
Teus van Laar
3. LCIG
Per Odin Sr.
4. LECIG
Dag Nyholm
5. Foslevodopa/Foscarbidopa
K Ray Chaudhuri and Karolina Poplawska-Domaszewicz
6. ND0612
Fabrizio Stocchi
7. STN-DBS
Elena Moro
8. Pallidal DBS
Keyoumars Ashkan
9. MRgFUS
Guenther Deuschl
10. Vestibular Neurostimulation
Aleksandra M. Podlewska
11. Patient selection and choice of therapy
Cristian Falup-Pecurariu
12. The future: Stem cells? Gene therapy?
Gesine Paul-Visse
13. The future: Trophic factors
Jeffrey H. Kordower
14. Devices and the dashboard for PD
K Ray Chaudhuri and Karolina Poplawska-Domaszewicz
Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.
Advanced Parkinson's disease; Akinesia; Apomorphine; Cell therapy; Cell therapy clinical trial; Clinical trials; Continuous dopaminergic stimulation; Continuous drug delivery; Continuous subcutaneous apomorphine infusion; DBS; DBS outcomes; Deep brain stimulation; Device aided therapies; Device-aided therapies; Dopaminergic neurons; Early morning off; Essential tremor; Focused ultrasound; Foslevodopa; Foslevodopa/foscarbidopa; Future treatment; Globus pallidus internus; Human embryonic stem cells; Induced pluripotent stem cells; Infusion; Intestinal gel; KeywordNeurotrophins; Levodopa; Levodopa-carbidopa intestinal gel; Levodopa-entacapone-carbidopa; Levodopa-entacapone-carbidopa intestinal gel; Motor fluctuations; Movement disorders; Neuromodulation; Parkinsonian tremor; Parkinson's disease; Pharmacokinetics; Pump; Response fluctuations; STN-DBS; Subcutaneous; Subcutaneous infusion; Subthalamic nucleus; Technical principles; Transplantation; Treatment of tremor